Access cutting-edge open-angle glaucoma treatment through this clinical trial at a research site in Fayetteville. Study-provided care at no cost to qualified participants.
Access open-angle glaucoma specialists in Fayetteville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related open-angle glaucoma treatment provided free
Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab externo approach. Adverse events and intraocular pressure will be assessed. XEN45 is an approved device for the treatment of glaucoma implanted using the ab interno approach (inside the eye). XEN45 implanted using the ab externo approach (outside the eye) is being studied in this study. Approximately 65 pa
Sponsor: AbbVie
Check if you qualify for this open-angle glaucoma clinical trial in Fayetteville, AR
If you're searching for open-angle glaucoma treatment options in Fayetteville, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fayetteville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced open-angle glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.